AAAAAA
Results:
1-11
|
Results: 11
Authors:
Mircescu, H
Gariepy, G
Belanger, R
Bedard, MJ
Nassif, E
Chartrand, R
Lavoie, HB
Citation: H. Mircescu et al., Papillary carcinoma within struma ovarii: A case report with literature review, ENDOCRINOLO, 11(5), 2001, pp. 413-420
Authors:
Wiseman, GA
White, CA
Sparks, RB
Erwin, WD
Podoloff, DA
Lamonica, D
Bartlett, NL
Parker, JA
Dunn, WL
Spies, SM
Belanger, R
Witzig, TE
Leigh, BR
Citation: Ga. Wiseman et al., Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of Zevalin (TM) radioimmunotherapy for low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma, CR R ONC H, 39(1-2), 2001, pp. 181-194
Authors:
Tyring, S
Belanger, R
Bezwoda, W
Ljungman, P
Boon, R
Saltzman, RL
Citation: S. Tyring et al., A randomized, double-blind trial of famciclovir versus acyclovir for the treatment of localized dermatomal herpes zoster in immunocompromised patients, CANCER INV, 19(1), 2001, pp. 13-22
Authors:
Le Blanc, R
Montminy-Metivier, S
Belanger, R
Busque, L
Fish, D
Roy, DC
Kassis, J
Boileau, J
Lavallee, R
Belanger, D
Letendre, F
Hebert, J
Sauvageau, G
Perreault, C
Roy, J
Citation: R. Le Blanc et al., Allogeneic transplantation for multiple myeloma: further evidence for a GVHD-associated graft-versus-myeloma effect, BONE MAR TR, 28(9), 2001, pp. 841-848
Authors:
Maltais, F
Simon, M
Jobin, J
Desmeules, M
Sullivan, MJ
Belanger, R
Leblanc, P
Citation: F. Maltais et al., Effects of oxygen on lower limb blood flow and O-2 uptake during exercise in COPD, MED SCI SPT, 33(6), 2001, pp. 916-922
Authors:
Gilbert, C
Roy, J
Belanger, R
Delage, R
Beliveau, C
Demers, C
Boivin, G
Citation: C. Gilbert et al., Lack of emergence of cytomegalovirus UL97 mutations conferring ganciclovir(GCV) resistance following preemptive GCV therapy in allogeneic stem cell transplant recipients, ANTIM AG CH, 45(12), 2001, pp. 3669-3671
Authors:
Goodfellow, R
Belanger, R
Citation: R. Goodfellow et R. Belanger, Hot tap installed on operating sour-gas line, OIL GAS J, 99(12), 2001, pp. 50
Authors:
Wiseman, GA
White, CA
Stabin, M
Dunn, WL
Erwin, W
Dahlbom, M
Raubitschek, A
Karvelis, K
Schultheiss, T
Witzig, TE
Belanger, R
Spies, S
Silverman, DHS
Berlfein, JR
Ding, E
Grillo-Lopezs, AJ
Citation: Ga. Wiseman et al., Phase I/II Y-90-Zevalin (yttrium-90 ibritumomab tiuxetan, IDEC-Y2B8) radioimmunotherapy dosimetry results in relapsed or refractory non-Hodgkin's lymphoma, EUR J NUCL, 27(7), 2000, pp. 766-777
Authors:
Boivin, G
Belanger, R
Delage, R
Beliveau, C
Demers, C
Goyette, N
Roy, J
Citation: G. Boivin et al., Quantitative analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay and the COBAS AMPLICOR CMV MONITOR PCR test after blood and marrow allogeneic transplantation, J CLIN MICR, 38(12), 2000, pp. 4356-4360
Authors:
Guimond, M
Busque, L
Baron, C
Bonny, Y
Belanger, R
Mattioli, J
Perreault, C
Roy, DC
Citation: M. Guimond et al., Relapse after bone marrow transplantation: Evidence for distinct immunological mechanisms between adult and paediatric populations, BR J HAEM, 109(1), 2000, pp. 130-137
Authors:
Lazarus, HM
Belanger, R
Candoni, A
Aoun, M
Jurewicz, R
Marks, L
Citation: Hm. Lazarus et al., Intravenous penciclovir for treatment of herpes simplex infections in immunocompromised patients: Results of a multicenter, acyclovir-controlled trial, ANTIM AG CH, 43(5), 1999, pp. 1192-1197
Risultati:
1-11
|